July 31, 2012

Affymax Announces Second Quarter 2012 Financial Results Teleconference and Webcast

PALO ALTO, Calif.--(BUSINESS WIRE)-- Affymax, Inc. (Nasdaq: AFFY) today announced that it will host a teleconference and webcast with management to provide a general business overview, as well as to discuss its second quarter 2012 financial results on Wednesday, August 8, 2012, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time). Financial results for the quarter ended June 30, 2012 will be released after market close on August 8, 2012.

Interested parties can listen to the live teleconference by dialing (866) 393-1565 from the U.S. or +1(973) 409-9608 for international callers. Individuals may access the live audio webcast by visiting: http://www.investors.affymax.com/events.cfm. A replay of the webcast will be available on the Company's website for 30 days following the live event.

About Affymax, Inc.

Affymax, Inc. is a biopharmaceutical company based in Palo Alto, California. Affymax's mission is to discover, develop and deliver innovative therapies that improve the lives of patients with kidney disease and other serious and often life-threatening illnesses.

The company's first marketed product, OMONTYS® (peginesatide) Injection, was approved by the U.S. Food and Drug Administration (FDA) in March 2012. For additional information, please visit www.affymax.com.

Affymax, Inc.
Alexandra Santos, 650-812-8961
Associate Director, Corporate Communications

Source: Affymax, Inc.

News Provided by Acquire Media


Close window | Back to top

Copyright 2014 Affymax, Inc.